From tracking LIMRA quarterly sales data against carrier 10-K filings since 2022, the correlation between IUL sales growth and carrier investment in digital distribution channels has become unmistakable. The Q1 2026 numbers confirm what carrier earnings have been signaling: life insurance and annuity demand has entered a structural growth phase that transcends short-term interest rate noise.
LIMRA released its Q1 2026 Individual Life Insurance and U.S. Individual Annuity Sales Survey results in May 2026, and the headline figures are striking. Life insurance new annualized premium plus excess rose 10% year over year to $4.5 billion. Total annuity sales of $104.6 billion came in just 2% below the all-time Q1 record set in 2025, marking the tenth consecutive quarter above the $100 billion threshold. Both results follow a 2025 in which individual life premium topped $17.5 billion (a record) and annuity sales reached $464.1 billion (also a record, for the fourth consecutive year).
This piece breaks down the product-level data on both sides, connects the numbers to the demographic and macroeconomic forces sustaining demand, and examines the actuarial implications for reserve adequacy, LDTI earnings volatility, and product development strategy.
Q1 2026 Individual Life Insurance: Product-Level Breakdown
Every major product line except fixed universal life posted positive premium growth in the first quarter. Policy count rose 9% across the market, suggesting that growth is broad-based rather than concentrated in a few large-face-amount cases.
| Product | Q1 2026 Premium | YoY Growth | Policy Count Change | Market Share |
|---|---|---|---|---|
| Whole Life | $1.6B | +9% | +13% | 36% |
| Indexed Universal Life (IUL) | $1.1B | +14% | +8% | 25% |
| Term Life | $788M | +9% | +5% | 18% |
| Variable Universal Life (VUL) | $729M | +12% | +4% | 16% |
| Fixed Universal Life | $221M | -6% | +5% | 5% |
Source: LIMRA U.S. Individual Life Insurance Sales Survey, Q1 2026.
IUL Extends Its Record Streak
Indexed universal life once again led the charge. Q1 2026 IUL new premium reached $1.1 billion, a 14% gain that pushed the product to records in four of the past five years. Six of the top ten IUL carriers reported double-digit premium growth. The full-year 2025 picture was even more striking: IUL new premium totaled a record $4.5 billion for the year, 17% above 2024 results, with IUL representing 25% of the total U.S. life insurance market.
This is not simply a function of higher interest rates improving crediting rates on the general account side. Carriers have expanded IUL distribution by launching simplified issue products that target middle-market consumers. LIMRA noted that simplified IUL and final expense products surged, particularly among lower- and middle-income consumers, producing double-digit policy growth not seen since the 1990s. That policy count signal matters: it means the IUL growth is coming from more buyers, not just larger policies.
Whole Life Remains the Largest Segment
Whole life held its position as the single largest product line at 36% market share, with $1.6 billion in new premium (up 9%) and policy count climbing 13%. The 13% policy count increase was the strongest of any product line, driven in part by captive agency systems at mutual carriers that continue to push participating whole life as a core protection product. Full-year 2025 whole life premium reached a record $6.4 billion, up 7% from 2024.
Fixed UL in Structural Decline
Fixed universal life was the lone negative outlier, declining 6% in premium for the sixth consecutive quarter. The product has been losing ground to IUL for years as consumers and distributors increasingly prefer the indexed crediting mechanism. Policy count still grew 5%, suggesting that the product retains a role in certain markets (notably final expense), but the premium contraction signals shrinking face amounts and competitive displacement.
Pacific Life Takes the Top Spot
Among carriers, Pacific Life made one of the largest moves, posting a 38% year-over-year premium increase to take the number-one writer position for the first quarter. Pacific Life finished 2024 in third place for the full year. Nationwide and Prudential also moved up the sales charts significantly. This reshuffling reflects both product competitiveness and distribution partnership shifts, with JD Power’s 2026 U.S. Life & Annuity Distribution Partner Experience Study ranking Pacific Life as the top-rated life insurance distribution partner based on advisor and agent feedback.
Q1 2026 Annuity Market: The Tenth Consecutive $100 Billion Quarter
Total U.S. annuity sales came in at $104.6 billion for Q1 2026, 2% below Q1 2025’s all-time first-quarter record. While the year-over-year comparison is slightly negative, the result extends a remarkable streak: ten straight quarters above $100 billion, a threshold the industry first reached in Q4 2023.
The product-level story reveals a pronounced mix shift favoring indexed and registered products over traditional fixed-rate deferred annuities.
| Product | Q1 2026 Sales | YoY Change | Key Trend |
|---|---|---|---|
| Fixed-Rate Deferred (FRD) | $34.0B | -16% | Normalizing from rate-lock rush; still one-third of market |
| Fixed Indexed Annuity (FIA) | $26.6B | -4% | Slight pullback from record pace |
| RILA | $21.2B | +21% | 30th consecutive quarter of YoY growth |
| Traditional Variable Annuity | $16.1B | +9% | Stabilized after years of secular decline |
| SPIA | $3.7B | +22% | Income-focused buying accelerates |
| DIA | $1.0B | +6% | Modest growth from small base |
Source: LIMRA U.S. Individual Annuity Sales Survey, Q1 2026. Survey represents 87% of the total U.S. annuity market.
RILAs: 30 Quarters and Counting
Registered index-linked annuities continued their extraordinary run, posting $21.2 billion in Q1 2026 sales, up 21% year over year and representing the second-highest sales quarter in product history. This was the 30th consecutive quarter of year-over-year growth, a streak unmatched by any other annuity product category.
The RILA growth story is structural, not cyclical. RILA volume has grown roughly tenfold over the past decade, from approximately $24 billion in 2020 to $79.6 billion in 2025. LIMRA is forecasting that 2026 RILA sales will exceed the record set in 2025. The expansion is driven by three reinforcing factors: more carriers entering the RILA market, more products with varied buffer and floor structures becoming available, and growing adoption by RIA and fee-based advisor channels that previously had limited access to annuity products.
For actuaries working on product design and hedging, the continued RILA expansion creates a compounding challenge. Unlike traditional fixed annuities, where the carrier bears primarily interest rate risk, RILA products embed equity-linked exposure through call-spread hedging strategies. As we analyzed in our RILA cap-rate pricing methodology piece, the cap-rate setting process depends on volatility surface calibration and general account earned-rate budgets. Higher volumes amplify the hedging infrastructure requirements and the sensitivity of ALM models to equity-rate correlation assumptions.
Fixed-Rate Deferred Normalization
The 16% decline in fixed-rate deferred (FRD) annuity sales, from $40.4 billion to $34.0 billion, represents the most significant product-level shift. FRD products more than doubled from pre-2022 levels during the rate-hiking cycle as consumers locked in yields above 5%. With the Fed holding rates steady through early 2026 and markets pricing limited rate cuts for the remainder of the year, the urgency to capture expiring rate guarantees has faded. FRD still represents roughly one-third of total annuity volume, but the product’s growth trajectory has clearly plateaued.
Income Annuity Uptick
The 22% surge in SPIA sales to $3.7 billion deserves attention beyond its modest absolute size. SPIAs convert accumulated assets into guaranteed lifetime income, and the buying acceleration suggests that a growing cohort of retirees is moving from the accumulation phase to the decumulation phase. Combined with the 6% DIA growth, income-focused annuity products totaled $4.7 billion in Q1 2026. Patterns we have seen in recent quarters suggest that the Peak 65 demographic wave is beginning to shift annuity demand from accumulation-oriented products toward payout-oriented structures.
The Peak 65 Demographic Engine
More than 4.1 million Americans are turning 65 each year through 2027, representing the largest surge of retirement-age adults in U.S. history. In 2025, an average of 11,400 Americans reached age 65 every day. This cohort sits at the intersection of two actuarial realities: declining access to defined benefit pension coverage and increasing longevity expectations.
LIMRA research shows that nearly 6 in 10 Gen X consumers, the generation now entering its peak retirement planning years, are concerned about outliving their savings. Yet only 1 in 5 pre-retirees currently own an annuity. That gap between concern and coverage represents the demand reservoir that carriers are tapping.
The demographic effect is not a one-year phenomenon. The baby boom birth cohort spans roughly 1946 to 1964, meaning the Peak 65 wave extends well into the late 2020s. This sustained demand profile distinguishes the current growth cycle from prior annuity booms that were almost entirely rate-driven. Even if the Fed resumes cutting rates in the second half of 2026, the demographic tailwind provides a demand floor that did not exist during prior easing cycles.
Bryan Hodgens, senior vice president of LIMRA Research, put it directly: “Product innovation, favorable economics, and Peak65 demographics are key tailwinds.” The indexed products, he noted, will continue growing as investors seek “downside protection coupled with investment growth.”
2026 Full-Year Outlook
Life Insurance
LIMRA forecasts overall life insurance new annualized premium growth of 2% to 6% for full-year 2026, slightly above the historical average of 3.1% but well below the double-digit surge of 2025. The moderation reflects economic headwinds: LIMRA noted that 52% of Americans are highly concerned about the economy, and consumer sentiment surveys show that tariff uncertainty is weighing on large financial commitments.
The 10% Q1 result sits well above the full-year forecast range, which suggests either that the forecast will be revised upward or that the remaining quarters will decelerate. From tracking prior LIMRA forecast-to-actual spreads, Q1 outperformance of this magnitude typically translates to a final result in the upper half of the forecast range rather than a full reversion to the midpoint.
LIMRA expects double-digit IUL sales growth to continue in 2026, supported by increased distribution reach as additional products become available. This is particularly notable given the product’s increasing complexity and the regulatory scrutiny that AG 49 illustration standards have attracted.
Annuities
LIMRA projects that 2026 annuity sales will remain above $450 billion. The 2025 result of $464.1 billion set the bar, and the Q1 2026 run rate of $418 billion annualized is tracking slightly below that level. Several forces support the optimistic outlook: maturing annuity contracts creating “money in motion” as surrender charges expire, continued product innovation in fee-based and contingent deferred annuity structures, and technology-driven distribution efficiencies that reduce the friction of the annuity sale process.
RILA sales specifically are forecast to exceed the 2025 record of $79.6 billion. Given the $21.2 billion Q1 pace, RILA is tracking toward roughly $85 billion annualized, consistent with the projection.
Interest Rate Sensitivity and Reserve Implications
The rate environment adds a layer of complexity to the sales growth story. The Federal Reserve held rates steady at its April 2026 meeting with a rare 8-4 vote dissent, and market expectations for the remainder of 2026 have shifted materially. Polymarket traders now price a 69% probability of zero rate cuts in 2026, a sharp reversal from the consensus view just months earlier.
For life actuaries, the interaction between sales volumes and rate expectations creates several reserve-related considerations:
LDTI discount rate volatility. Under ASU 2018-12, the liability for future policyholder benefits is remeasured using upper-medium-grade fixed-income yields updated quarterly. After 12 quarters of LDTI reporting, market remeasurement swings routinely move life insurer net income by 10% to 25%, as we documented in our LDTI year-three earnings volatility analysis. If rates remain elevated through year-end, the AOCI impact will be muted relative to 2022 and 2023, but the sensitivity analysis in statutory opinions still needs to address a wider range of rate scenarios than a year ago.
Fixed annuity credited rate management. Carriers that sold large volumes of fixed-rate deferred annuities at 5%+ credited rates during 2023 and 2024 face a portfolio rate drag if new money rates decline. Rona Guymon, senior vice president of Nationwide Annuity Distribution, noted that rates “remain high enough to continue offering strong rates across fixed annuity products for the next few years.” But even a 50 to 100 basis point decline in reinvestment yields can meaningfully compress the investment spread, particularly for carriers whose credited rate floors sit close to current earned rates.
VM-22 and RILA reserve adequacy. The continued growth of RILA and FIA volumes increases the aggregate exposure of life insurer balance sheets to equity-linked guarantees. VM-22 reserve requirements for indexed products rely on stochastic scenario testing. As the Generator of Economic Scenarios (GOES) framework moves toward its Summer 2026 field test, valuation actuaries will need to assess whether existing scenario sets adequately capture the correlation structures embedded in their growing indexed product blocks.
Product Innovation Driving New Market Segments
Beyond the top-line numbers, the Q1 data reflects a product landscape that is broadening significantly.
Hybrid life/LTC products. As the standalone LTC market contracted over the past decade, with major carriers exiting after catastrophic mispricing of legacy blocks, hybrid products combining life insurance or annuity chassis with long-term care benefits have captured the growing awareness of long-term care risk. The majority of new LTC coverage sold in the U.S. today comes through hybrid structures, and the 1035 exchange provision allows tax-efficient repositioning of existing annuity assets into hybrid products. This trend intersects directly with Peak 65 demand and helps explain why whole life and IUL policy counts are growing faster than face amounts might suggest.
Fee-based annuities. LIMRA expects continued expansion of fee-based annuity products and contingent deferred annuities that allow clients to maintain control of their invested assets while adding guaranteed income protection. Fee-based structures have doubled in sales since 2020, driven primarily by RIA channel adoption. For product actuaries, fee-based annuities present a different economic profile: lower per-policy general account investment income but higher persistency and reduced disintermediation risk, since the advisor’s ongoing fee creates a retention incentive.
Simplified issue expansion. The IUL growth story is incomplete without acknowledging the distribution innovation behind it. Carriers are launching simplified issue IUL products that reduce the underwriting friction for middle-market buyers, shrinking application-to-issue timelines from weeks to days. LIMRA attributed part of the double-digit policy growth to these simplified products reaching lower- and middle-income segments that have historically been underserved by the life insurance industry.
Why This Matters for Actuaries
The Q1 2026 data carries several implications for practicing actuaries across pricing, valuation, and product roles.
Pricing actuaries should note the acceleration in IUL and RILA volumes as a signal that competitive pressure on crediting rates, cap rates, and participation rates is intensifying. With more carriers entering the indexed product space and distribution expanding into fee-only channels, the margin compression that typically accompanies volume growth is already visible in the cap-rate data. ASOP No. 25 credibility procedures become increasingly important as experience data on newer indexed product designs remains thin.
Valuation actuaries face a compounding workload as the sheer volume of LDTI-subject contracts grows. Every dollar of the $4.5 billion in Q1 life premium and the $104.6 billion in annuity sales enters the liability for future policyholder benefits or the market risk benefit (MRB) calculations. The quarterly remeasurement cycle under LDTI does not scale linearly with volume; it scales with the complexity of the product mix, and the product mix is shifting toward more complex indexed structures that require stochastic modeling.
Product development actuaries should track the SPIA and DIA uptick as an early signal that decumulation product demand is starting to match the accumulation growth that has defined the annuity market since 2022. The 22% SPIA growth in Q1 2026 marks an inflection that could accelerate as more Peak 65 participants move past the savings phase. Carriers with robust payout annuity platforms may find a less competitive environment than the crowded FIA and RILA space.
Capital modeling. The NAIC’s pending C-3 field test using the GOES framework and the C-2 longevity risk RBC charge under development will both interact with the growing volumes of indexed and payout products on carrier balance sheets. Life actuaries involved in capital planning should begin assessing how the portfolio composition shift, from traditional fixed products toward indexed and income-oriented structures, affects risk-based capital requirements under the emerging framework.
The Bottom Line
The Q1 2026 data confirms that life insurance and annuity sales have entered a sustained growth phase driven by demographics, product innovation, and a rate environment that, even if it moderates, remains favorable by historical standards. Individual life premium at $4.5 billion (up 10%), annuity sales at $104.6 billion (the tenth consecutive $100 billion quarter), and RILA growth at 21% are not anomalies to be explained away. They are the new baseline against which carriers will allocate capital, build products, and compete for distribution relationships.
For life actuaries, the volume growth is a positive signal for the industry’s relevance and financial health. But it also means that reserve adequacy, hedging infrastructure, LDTI earnings volatility management, and product pricing discipline will all be tested at scale. The next data release to watch is the full-year 2025 LIMRA annuity report (final figures confirmed at $464.1 billion) and the Q2 2026 results, which will indicate whether the Q1 pace holds through the seasonally slower summer months.